Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:1954-1959
Published online before print October 6, 2003, doi: 10.1161/01.CIR.0000091410.19963.9A
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/16/1954    most recent
01.CIR.0000091410.19963.9Av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Burg, A. E. B.
Right arrow Articles by Schalij, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Burg, A. E. B.
Right arrow Articles by Schalij, M. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Arrhythmia
*Cardiac Arrest
*Coronary Artery Disease
*Scars
Related Collections
Right arrow Nuclear cardiology and PET

(Circulation. 2003;108:1954.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Impact of Viability, Ischemia, Scar Tissue, and Revascularization on Outcome After Aborted Sudden Death

Alida E. Borger van der Burg, MD; Jeroen J. Bax, MD; Eric Boersma, PhD; Ernest K.J. Pauwels, MD; Ernst E. van der Wall, MD; Martin J. Schalij, MD

From the Department of Cardiology, Leiden University Medical Center, Leiden, and Department of Epidemiology/Statistics (E.B.), Erasmus University Rotterdam, the Netherlands.

Correspondence to Jeroen J. Bax, MD, PhD, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, the Netherlands. E-mail jbax{at}knoware.nl

Received February 24, 2003; de novo received May 21, 2003; revision received July 22, 2003; accepted July 22, 2003.

Background— Survivors of aborted sudden death attributable to ventricular arrhythmias in the presence of coronary artery disease are at risk for recurrences. The substrate underlying these arrhythmias is not clear, and therefore the relation between ischemia, viability, scar tissue (and revascularization), and the incidence of ventricular arrhythmias (and survival) was studied over up to 3 years.

Methods and Results— One hundred fifty-three survivors of sudden death underwent stress-rest perfusion imaging. Patients with ischemic/viable myocardium (n=73) were revascularized if possible. Final antiarrhythmic therapy was based on the outcome of electrophysiological testing or left ventricular ejection fraction (LVEF). Implantation of a defibrillator was performed in 112 (72%) patients. During 3-year follow-up, 15 cardiac deaths occurred and 42 (29%) patients had recurrent ventricular arrhythmias. Patients with events (death or recurrence) exhibited more often a severely depressed LVEF (<=30%), more extensive scar tissue, and less ischemic/viable myocardium on perfusion imaging and less frequently underwent revascularization. Multivariate analysis identified extensive scar tissue and LVEF <=30% as the only predictors of death/recurrent ventricular arrhythmias.

Conclusions— In patients with aborted sudden death, extensive scar tissue and severely depressed LVEF are the only predictors of death or recurrent ventricular arrhythmias. These patients should be considered for implantation of a defibrillator.


Key Words: ischemia • arrhythmia • death, sudden




This article has been cited by other articles:


Home page
EuropaceHome page
P. Pascale, J. Schlaepfer, M. Oddo, M.-D. Schaller, P. Vogt, and M. Fromer
Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization
Europace, December 1, 2009; 11(12): 1639 - 1646.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Kelle, S. D. Roes, C. Klein, T. Kokocinski, A. de Roos, E. Fleck, J. J. Bax, and E. Nagel
Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging.
J. Am. Coll. Cardiol., November 3, 2009; 54(19): 1770 - 1777.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. J. W. Borleffs, L. van Erven, M. Schotman, E. Boersma, P. Kies, A. E. B. van der Burg, K. Zeppenfeld, M. Bootsma, E. E. van der Wall, J. J. Bax, et al.
Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT)
Eur. Heart J., July 1, 2009; 30(13): 1621 - 1626.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
J. P. Piccini, J. R. Horton, L. K. Shaw, S. M. Al-Khatib, K. L. Lee, A. E. Iskandrian, and S. Borges-Neto
Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death
Circ Cardiovasc Imaging, November 1, 2008; 1(3): 180 - 188.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. M. Gillis
Tincture of Time: When to Implant a Prophylactic Cardioverter-Defibrillator Following Coronary Revascularization?
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1818 - 1819.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. S. Chauhan, E. Downar, K. Nanthakumar, J. D. Parker, H. J. Ross, W. Chan, and P. Picton
Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H79 - H86.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Elhendy, S. Chapman, T. R. Porter, and J. Windle
Association of Myocardial Ischemia With Mortality and Implantable Cardioverter-Defibrillator Therapy in Patients With Coronary Artery Disease at Risk of Arrhythmic Death
J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1721 - 1726.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Nazarian, D. A. Bluemke, A. C. Lardo, M. M. Zviman, S. P. Watkins, T. L. Dickfeld, G. R. Meininger, A. Roguin, H. Calkins, G. F. Tomaselli, et al.
Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy
Circulation, November 1, 2005; 112(18): 2821 - 2825.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
T. J. Bunch, S. C. Hammill, and R. D. White
Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival
Mayo Clin. Proc., June 1, 2005; 80(6): 774 - 782.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
D. Bello, D. S. Fieno, R. J. Kim, F. S. Pereles, R. Passman, G. Song, A. H. Kadish, and J. J. Goldberger
Infarct morphology identifies patients with substrate for sustained ventricular tachycardia
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1104 - 1108.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons and P. A. Araoz
The year in cardiac imaging
J. Am. Coll. Cardiol., November 16, 2004; 44(10): 1937 - 1944.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Lampert, C. A. McPherson, J. F. Clancy, T. L. Caulin-Glaser, L. E. Rosenfeld, and W. P. Batsford
Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators
J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2293 - 2299.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. M. Canty Jr, G. Suzuki, M. D. Banas, F. Verheyen, M. Borgers, and J. A. Fallavollita
Hibernating Myocardium: Chronically Adapted to Ischemia but Vulnerable to Sudden Death
Circ. Res., April 30, 2004; 94(8): 1142 - 1149.
[Abstract] [Full Text] [PDF]